Citigroup’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $71.5K | Sell |
4,508
-2,668
| -37% | -$46.6K | ﹤0.01% | 4393 |
|
|
2025
Q4 | $127K | Buy |
7,176
+5,587
| +352% | +$97.8K | ﹤0.01% | 4211 |
|
|
2025
Q3 | $29.4K | Sell |
1,589
-5,128
| -76% | -$106K | ﹤0.01% | 4669 |
|
|
2025
Q2 | $144K | Sell |
6,717
-5,712
| -46% | -$123K | ﹤0.01% | 4223 |
|
|
2025
Q1 | $306K | Sell |
12,429
-1,247
| -9% | -$30.8K | ﹤0.01% | 3941 |
|
|
2024
Q4 | $317K | Buy |
13,676
+1,734
| +15% | +$43.4K | ﹤0.01% | 4121 |
|
|
2024
Q3 | $324K | Buy |
11,942
+8,248
| +223% | +$250K | ﹤0.01% | 4023 |
|
|
2024
Q2 | $106K | Buy |
3,694
+1,020
| +38% | +$31.3K | ﹤0.01% | 4180 |
|
|
2024
Q1 | $78K | Buy |
2,674
+392
| +17% | +$11K | ﹤0.01% | 4406 |
|
|
2023
Q4 | $74.2K | Sell |
2,282
-4,130
| -64% | -$120K | ﹤0.01% | 4326 |
|
|
2023
Q3 | $205K | Sell |
6,412
-4,846
| -43% | -$187K | ﹤0.01% | 3650 |
|
|
2023
Q2 | $494K | Buy |
11,258
+4,686
| +71% | +$216K | ﹤0.01% | 3387 |
|
|
2023
Q1 | $291K | Buy |
6,572
+507
| +8% | +$22.4K | ﹤0.01% | 3512 |
|
|
2022
Q4 | $241K | Sell |
6,065
-1,752
| -22% | -$73K | ﹤0.01% | 3627 |
|
|
2022
Q3 | $361K | Sell |
7,817
-1,064
| -12% | -$52.2K | ﹤0.01% | 3468 |
|
|
2022
Q2 | $384K | Sell |
8,881
-522
| -6% | -$23.9K | ﹤0.01% | 3417 |
|
|
2022
Q1 | $508K | Sell |
9,403
-3,415
| -27% | -$174K | ﹤0.01% | 3488 |
|
|
2021
Q4 | $767K | Buy |
12,818
+1,313
| +11% | +$81.7K | ﹤0.01% | 3497 |
|
|
2021
Q3 | $754K | Sell |
11,505
-29,552
| -72% | -$1.92M | ﹤0.01% | 3306 |
|
|
2021
Q2 | $2.6M | Buy |
41,057
+317
| +0.8% | +$18.2K | ﹤0.01% | 2460 |
|
|
2021
Q1 | $1.99M | Buy |
40,740
+4,576
| +13% | +$220K | ﹤0.01% | 2496 |
|
|
2020
Q4 | $1.49M | Buy |
36,164
+9,699
| +37% | +$445K | ﹤0.01% | 3132 |
|
|
2020
Q3 | $1.21M | Sell |
26,465
-9,231
| -26% | -$428K | ﹤0.01% | 3096 |
|
|
2020
Q2 | $1.56M | Buy |
35,696
+25,898
| +264% | +$1.16M | ﹤0.01% | 3096 |
|
|
2020
Q1 | $388K | Buy |
9,798
+7,118
| +266% | +$319K | ﹤0.01% | 4111 |
|
|
2019
Q4 | $126K | Buy |
2,680
+1,675
| +167% | +$64.9K | ﹤0.01% | 5552 |
|
|
2019
Q3 | $35K | Sell |
1,005
-1,444
| -59% | -$50K | ﹤0.01% | 6361 |
|
|
2019
Q2 | $95K | Buy |
2,449
+283
| +13% | +$11.4K | ﹤0.01% | 5930 |
|
|
2019
Q1 | $96K | Buy |
2,166
+499
| +30% | +$19K | ﹤0.01% | 5778 |
|
|
2018
Q4 | $58K | Sell |
1,667
-236
| -12% | -$7.48K | ﹤0.01% | 6111 |
|
|
2018
Q3 | $70K | Buy |
1,903
+907
| +91% | +$27.8K | ﹤0.01% | 6231 |
|
|
2018
Q2 | $27K | Buy |
996
+383
| +62% | +$8.17K | ﹤0.01% | 6768 |
|
|
2018
Q1 | $9K | Buy |
613
+88
| +17% | +$1.56K | ﹤0.01% | 7085 |
|
|
2017
Q4 | $10K | Buy |
+525
| New | +$10K | ﹤0.01% | 7041 |
|
Other funds holding KIDS
B
GIM
VCM
SCM
Citigroup's KIDS Position: Q1 2026 in Review
Citigroup reduced its OrthoPediatrics (KIDS) stake by 37% in Q1 2026, selling an estimated $46.6K and leaving 4,508 shares worth $71.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4393.
Citigroup first reported a position in KIDS in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.6M in Q2 2021. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.
- Citigroup held 4,508 shares of OrthoPediatrics worth $71.5K as of Q1 2026.
- Citigroup sold 2,668 OrthoPediatrics shares in Q1 2026, an estimated $46.6K.
- OrthoPediatrics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4393 holding.
- Citigroup first reported a position in OrthoPediatrics in Q4 2017 and has held it in 34 quarters since.
- Citigroup's OrthoPediatrics position peaked at $2.6M in Q2 2021.
- 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.